Know Diabetes by Heart™ Professional Education Podcast Series focuses on the link between cardiovascular disease (CVD) and type 2 diabetes (T2D). The series will consist of relevant cutting-edge topics such as up-to-date standards of care, guidelines and their implications for T2D and CVD, and approaches to shared decision making — among other topics.
2020 Episode 10 – Managing CV and Renal Risk in Patients with T2D
Patients with T2D and CKD have a very high risk of CV events. Listen as Dr. Jorge Plutzky and Dr. Neha Pagidipati discuss new therapies to manage cardiovascular and renal risk in patients with T2D. Their discussion is based on new science presented during AHA Scientific Sessions 2020.
2020 Episode 9 – Health Disparities in Diagnosis and Treatment
Listen as Dr. Eduardo Sanchez from the American Heart Association and Dr. Robert Gabbay from the American Diabetes Association discuss social determinants of health and disparities in health and health care in individuals with type 2 diabetes at risk for cardiovascular disease and COVID-19 and what can be done to improve their outcomes.
2020 Episode 8 – Cardiorenal Protection in Patients with Diabetes and CKD
Listen to leading experts discuss the new Scientific Statement from the American Heart Association, “Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease,” where two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart disease.
2020 Episode 6 – Clinical Management of Stable Coronary Artery Disease in Patients with T2D
Listen to members of the writing group for the new AHA statement on the clinical management of stable coronary artery disease in patients with T2D. Dr. Suzanne Arnold, Chair, and fellow writing group members, Dr. Prakash Deedwania and Dr. Mikhail Kosiborod will review highlights from the statement, including recent clinical trials which uncovered several new drugs that not only reduce glucose but also improve cardiovascular and renal outcomes.
2020 Episode 4 – Heart Failure Management in Patients with T2D and CVD
Listen to Dr. Nancy Albert, a clinical nurse specialist and lead researcher in heart failure and Dr. Mikhail Kosiborod, a cardiologist and expert in the fields of diabetes, cardiovascular diseases, cardiometabolic and cardiorenal syndromes, and quality care and outcomes discuss heart failure management in patients with type 2 diabetes and cardiovascular disease.
2020 Episode 2 – The Patient Journey
Listen to Dr. Jorge Plutzky, a cardiologist, and Dr. Joshua Joseph, an endocrinologist, discuss with patients the challenges and barriers they face living with type 2 diabetes and cardiovascular disease, and how health care providers can best support them.
2019 Episode 10 – Lifestyle Management for Prevention of CVD
Goal setting and discussing lifestyle management with your patients is critical in managing the link between diabetes and heart disease. Listen to Dr. Nathanial Clark, an endocrinologist, and Melissa Magwire, a nurse and CDE (Certified Diabetes Educator) discuss how to initiate the conversation and set your patient up for success.
2019 Episode 9 – Role of the Cardiologist in Treatment of T2D and CVD Risk Management
In a recent survey of people age 45 and older with type 2 diabetes, conducted online by The Harris Poll, only half recognize their cardiovascular risk or have discussed their risk of heart attacks or strokes with their health care providers. Listen to cardiologist, Dr. Tracy Wang and endocrinologist, Dr. Robert Eckel discuss how a cardiologist can play a pivotal role in helping his/her patients with type 2 diabetes better manage their cardiovascular disease risk.
2019 Episode 8 – Use of Anti-hyperglycemic Agents with CVD Benefits
The management of type 2 diabetes to prevent cardiovascular disease has been focused on glycemic control and the use of drugs based on their ability to lower levels of glycemia. Listen to Dr. Robert Eckel and Dr. Chris Cannon discuss the use of anti-hyperglycemic agents with CVD benefits.
2019 Episode 7 – Benefits of Diabetes Educator Referrals
Diabetes education has positive effects not only on psychosocial and behavioral aspects of diabetes care, but also known to be a cost-effective treatment by reducing hospital readmissions and lowered risk for complications. Yet, many patients often do not receive DSMES (Diabetes Self-Management Education and Support) referrals. Listen to Nancy D’Hondt, a certified diabetes educator and registered pharmacist, Dr. Lillian Khor, a cardiologist and Dr. Jay Shubrook, an osteopathic family physician, discuss how they work with CDEs and the benefits found from referring patients to diabetes self-management programs and a certified diabetes educator.
2019 Episode 6 – Diabetes and Heart Failure
Identifying and implementing optimal treatment strategies for patients living with diabetes and heart failure is critical to improving outcomes for this population. Shannon Dunlay, MD, MS discusses managing patients with diabetes who are at risk for heart failure or those that have heart failure. This podcast is based on the new scientific statement from the American Heart Association and the Heart Failure Society of America.
2019 Episode 5 – ASCVD Risk Calculator
The ASCVD Risk Calculator is a tool that enables healthcare providers and patients to estimate 10-year risk for atherosclerotic cardiovascular disease or ASCVD. Salim Virani, MD discusses the ASCVD risk calculator and why this assessment needs to be performed in patients with diabetes.
2019 Episode 4 – Shared Decision-Making
Shared decision-making is an effective approach to ensure patient and family involvement in decision-making and tailoring of treatment plans to meet goals. Jay Shubrook, DO, Robert Eckel, MD, and Patricia Montesinos, CRNP, CDE discuss how to interview and bring their patients to a collaborative discussion and joint treatment plan.
2019 Episode 3 – American Heart Association’s 2018 Cholesterol Guidelines and the Implications for Type 2 Diabetes
For people with diabetes, blood glucose isn’t the only important factor to track. New guidelines suggest the more than 110 million U.S. adults with diabetes or prediabetes should also manage their cholesterol as well as their blood glucose. Drs. Ronald Goldberg and Robert Eckel discuss the new American Heart Association’s 2018 Cholesterol Guidelines, released in November 2018 and the implications for type 2 diabetes along with pharmacotherapy and lifestyle interventions.
Episode 2 – Management and Treatment of Diabetes to Prevent Cardiovascular
In a recent survey of people age 45 and older with T2D, only about half recognize their risk or have discussed their risk for heart attacks or strokes with their healthcare providers. Drs. Christopher Cannon and Ronald Goldberg will discuss the management and treatment of diabetes to prevent cardiovascular disease in the new American Diabetes Association’s 2019 Standards of Care.
Episode 1 – Know Diabetes by Heart™Initiative Discussion
More than 30 million American adults have diagnosed or undiagnosed diabetes, putting them at risk for having cardiovascular disease. Dr. Eduardo Sanchez from the American Heart Association and Dr. William Cefalu from the American Diabetes Association discuss the link between CVD and T2D.